Discover the latest pharma quality and manufacturing trends.
Some of the most sought-after human experiences are health and happiness. Although pharmaceutical companies can’t determine personal happiness, they are having more to do with personal health outcomes that can tip the scale. The demand for personalized medicines, cell and gene therapies, hyper- responsive and patient-centric healthcare, and real-world data fueled by artificial intelligence (AI) platforms and stored in the cloud are just some examples of the personal touch that is driving the future of pharma.
Companies will need to operate with lower costs and shorter timelines while maintaining quality and encouraging innovation. That means reimagining work, tech- enabling the organization, and advancing the portfolio to achieve multiple objectives imultaneously.
Common Challenges With Manual Systems
Pharmaceutical companies that adopt a modern MES overcome these issues.
Notable gaps in traditional quality management system offerings:
Current technology trends are influencing consumer behavior and reshaping the way industry operates. Although pharma companies are working steadily to leverage the power of data and become more agile and resilient, there is still room for improvement.
Trending Topics
The FDA cannot ignore that the science and context in which previous regulatory decisions were made has changed, and we must be flexible to evolve with the data.
The key to pharma companies finding opportunities for growth is finding silver linings in regulatory challenges. Complementing regulatory efforts by promoting production and controls innovations will allow pharma leaders to improve patient outcomes and consequently extend their own reach.
Trending Topics
Actionable health insights, driven by radically interoperable data and artificial intelligence (AI), can help clinicians and consumers identify illness much earlier than we do today. Shifts in how diseases are identified, prevented, treated, or cured may lead to fundamentally different business models for traditional biopharma companies and new entrants.
AI is revolutionizing healthcare and manufacturing ... AI can help every sector gain insights into underused or unutilized resources, regular analysis, language and economic obstacles, and existing abilities, as well as achieve quality goals.
As the pharma industry strives to stay abreast of personalized patient needs, the number of holistic therapies dedicated to enhancing wellness – in addition to simply treating widespread disease – is rising.
Trending Topics
As of August 2023, there have been six regulatory approvals of a cell or gene therapy between the U.S. and the EU, with up to 9 scheduled for approval in 2023 – matching the number of approvals by the FDA in the previous five years combined.
The expected burden of [mental health disorders] could be reduced by around 24% by 2040 using existing therapies and cognitive behavioral therapies alone. Development of novel therapies to address the remaining 76% would only increase the potential value of investment in this area.
There’s going to have to be a tool to sort out which patients get the right drugs. If you only get 20% of the market, but it’s the right 20% of the market, you’re going to dominate that part, and that’s where you find the value of precision medicine.
Trending Topics
Companies that truly scale and implement digital can better protect themselves from the pressures of the forces increasing costs for the industry. More and more companies are moving toward network-wide and end-to-end digitization ... the rewards can include significant cost savings, improved quality, and increased resilience, as well as greater employee effectiveness.
Quality improvements gained by manufacturers who fully digitized production:
While pharma has traditionally been characterized by costly and lengthy development cycles, ever-evolving demands, driven largely by needs for more personalization, will require significant changes to pharmaceutical manufacturing and quality processes. The deeper digitalization can go into these companies, the more personalized their products can become – more efficiently, and consequently less expensively. Reaching digital maturity remains the imperative to enable companies to respond more quickly with flexibility and agility, while remaining compliant and competitive
Digital transformation in pharma is only expected to grow over the next few years to keep pace with current trends. Configurable solutions and intelligent platforms are making it possible to harmonize unique business processes with changing regulations and market demands. Now is the time to leverage professional expertise, differentiate, and expand your reach with a personal touch like never before.